Stocktoria
ASSEMBLY BIOSCIENCES, INC. ASMB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-12-17
ASSEMBLY BIOSCIENCES, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -16.8% | -159.3% | -902.5% | — | -2121.7% |
| Net margin | -8.5% | -140.9% | -854.8% | — | -2076.4% |
| FCF margin | -56.9% | -179.3% | 313.9% | — | -1542.9% |
| Return on assets | -2.4% | -33.7% | -44.7% | -91.5% | -68.0% |
| Return on equity | -3.0% | -120.4% | -149.0% | -112.6% | -76.9% |
| Current ratio | 5.22 | 2.42 | 3.41 | 5.95 | 9.59 |
| Revenue growth | 153.5% | 298.2% | — | -100.0% | -92.1% |
Source: SEC EDGAR filings · CIK 0001426800 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.